Lycopene as a potential anticancer agent: Current evidence on synergism, drug delivery systems and epidemiology (Review)
- Authors:
- Siliang Yin
- Xiuqing Xu
- Yi Li
- Heng Fang
- Junling Ren
-
Affiliations: Pharmaceutical Research Institute, Guangshengyuan Traditional Chinese Medicine Co., Ltd., Datong, Shanxi 037000, P.R. China, GAP Center, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, P.R. China - Published online on: July 28, 2025 https://doi.org/10.3892/ol.2025.15208
- Article Number: 462
-
Copyright: © Yin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.PubMed/NCBI | |
|
Bizuayehu HM, Ahmed KY, Kibret GD, Dadi AF, Belachew SA, Bagade T, Tegegne TK, Venchiarutti RL, Kibret KT, Hailegebireal AH, et al: Global disparities of cancer and its projected burden in 2050. JAMA Netw Open. 7:e24431982024. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel RL, Kratzer TB, Giaquinto AN, Sung H and Jemal A: Cancer statistics, 2025. CA Cancer J Clin. 75:10–45. 2025.PubMed/NCBI | |
|
Song X, Luo Y, Ma L, Hu X, Simal-Gandara J, Wang LS, Bajpai VK, Xiao J and Chen F: Recent trends and advances in the epidemiology, synergism, and delivery system of lycopene as an anti-cancer agent. Semin Cancer Biol. 73:331–346. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Atanasov AG, Zotchev SB, Dirsch VM; International Natural Product Sciences Taskforce, ; Supuran CT: Natural products in drug discovery: Advances and opportunities. Nat Rev Drug Discov. 20:200–216. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Kang H, Hoang DH, Valerio M, Pathak K, Graff W, LeVee A, Wu J, LaBarge MA, Frankhouser D, Rockne RC, et al: Pharmacological activity of OST-01, a natural product from baccharis coridifolia, on breast cancer cells. J Hematol Oncol. 18:162025. View Article : Google Scholar : PubMed/NCBI | |
|
Lin X and Zhang J, Chu Y, Nie Q and Zhang J: Berberine prevents NAFLD and HCC by modulating metabolic disorders. Pharmacol Ther. 254:1085932024. View Article : Google Scholar : PubMed/NCBI | |
|
Wang YH, Zhang RR, Yin Y, Tan GF, Wang GL, Liu H, Zhuang J, Zhang J, Zhuang FY and Xiong AS: Advances in engineering the production of the natural red pigment lycopene: A systematic review from a biotechnology perspective. J Adv Res. 46:31–47. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Wei RR, Lin QY, Adu M, Huang HL, Yan ZH, Shao F, Zhong GY, Zhang ZL, Sang ZP, Cao L and Ma QG: The sources, properties, extraction, biosynthesis, pharmacology, and application of lycopene. Food Funct. 14:9974–9998. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Grabowska M, Wawrzyniak D, Rolle K, Chomczynski P, Oziewicz S, Jurga S and Barciszewski J: Let food be your medicine: nutraceutical properties of lycopene. Food Funct. 10:3090–3102. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kulawik A, Cielecka-Piontek J and Zalewski P: The importance of antioxidant activity for the health-promoting effect of lycopene. Nutrients. 15:38212023. View Article : Google Scholar : PubMed/NCBI | |
|
Li N, Wu X, Zhuang W, Xia L, Chen Y, Wu C, Rao Z, Du L, Zhao R, Yi M, et al: Tomato and lycopene and multiple health outcomes: Umbrella review. Food Chem. 343:1283962021. View Article : Google Scholar : PubMed/NCBI | |
|
Amorim ADGN, Vasconcelos AG, Souza J, Oliveira A, Gullon B, de Souza de Almeida Leite JR and Pintado M: Bio-availability, anticancer potential, and chemical data of lycopene: An overview and technological prospecting. Antioxidants (Basel). 11:3602022. View Article : Google Scholar : PubMed/NCBI | |
|
Mazidi M, Ferns GA and Banach M: A high consumption of tomato and lycopene is associated with a lower risk of cancer mortality: Results from a multi-ethnic cohort. Public Health Nutr. 23:1569–1575. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Eliassen AH, Liao X, Rosner B, Tamimi RM, Tworoger SS and Hankinson SE: Plasma carotenoids and risk of breast cancer over 20 y of follow-up. Am J Clin Nutr. 101:1197–1205. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhuang E, Uchio E, Lilly M, Zi X and Fruehauf JP: A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer. Biomed Pharmacother. 143:1122262021. View Article : Google Scholar : PubMed/NCBI | |
|
Sahin K, Tuzcu M, Sahin N, Akdemir F, Ozercan I, Bayraktar S and Kucuk O: Inhibitory effects of combination of lycopene and genistein on 7,12-dimethyl benz(a)anthracene-induced breast cancer in rats. Nutr Cancer. 63:1279–1286. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Mennati A, Rostamizadeh K, Manjili HK, Fathi M and Danafar H: Co-delivery of siRNA and lycopene encapsulated hybrid lipid nanoparticles for dual silencing of insulin-like growth factor 1 receptor in MCF-7 breast cancer cell line. Int J Biol Macromol. 200:335–349. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Michael McClain R and Bausch J: Summary of safety studies conducted with synthetic lycopene. Regul Toxicol Pharmacol. 37:274–285. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Shao A and Hathcock JN: Risk assessment for the carotenoids lutein and lycopene. Regul Toxicol Pharmacol. 45:289–298. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Trumbo PR: Are there adverse effects of lycopene exposure? J Nutr. 135:2060S–2061S. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Imran M, Ghorat F, Ul-Haq I, Ur-Rehman H, Aslam F, Heydari M, Shariati MA, Okuskhanova E, Yessimbekov Z, Thiruvengadam M, et al: Lycopene as a natural antioxidant used to prevent human health disorders. Antioxidants (Basel). 9:7062020. View Article : Google Scholar : PubMed/NCBI | |
|
National Academy of Medicine, . Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academies Press; Washington, DC: 2000 | |
|
Aguilar F, Autrup H, Barlow S, Castle L, Crebelli R, Dekant W, Engel KH, Gontard N, Gott D, Grilli S, et al: Use of lycopene as a food colour scientific opinion of the panel on food additives, flavourings, processing aids and materials in contact with food. efsa J. 674:1–66. 2008. | |
|
Kavanaugh CJ, Trumbo PR and Ellwood KC: The U.S. Food and drug administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J Natl Cancer Inst. 99:1074–1085. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Rao AV and Agarwal S: Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer. 31:199–203. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Paetau I, Rao D, Wiley ER, Brown ED and Clevidence BA: Carotenoids in human buccal mucosa cells after 4 wk of supplementation with tomato juice or lycopene supplements. Am J Clin Nutr. 70:490–494. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Paetau I, Khachik F, Brown ED, Beecher GR, Kramer TR, Chittams J and Clevidence BA: Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in humans. Am J Clin Nutr. 68:1187–1195. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Yang Y and Wang Q: Lycopene can reduce prostate-specific antigen velocity in a phase II clinical study in Chinese population. Chin Med J (Engl). 127:2143–2146. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gann PH, Deaton RJ, Rueter EE, van Breemen RB, Nonn L, Macias V, Han M and Ananthanarayanan V: A phase II Randomized trial of lycopene-rich tomato extract among men with high-grade prostatic intraepithelial neoplasia. Nutr Cancer. 67:1104–1112. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Voskuil DW, Vrieling A, Korse CM, Beijnen JH, Bonfrer JM, van Doorn J, Kaas R, Oldenburg HS, Russell NS, Rutgers EJ, et al: Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer risk. Nutr Cancer. 60:342–353. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lilly MB, Wu C, Ke Y, Chen WP, Soloff AC, Armeson K, Yokoyama NN, Li X, Song L, Yuan Y, et al: A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients. Clin Transl Med. 14:e16272024. View Article : Google Scholar : PubMed/NCBI | |
|
Veeramachaneni S, Ausman LM, Choi SW, Russell RM and Wang XD: High dose lycopene supplementation increases hepatic cytochrome P4502E1 protein and inflammation in alcohol-fed rats. J Nutr. 138:1329–1335. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Tanaka A, Miyauchi T, Kitamura S, Iwata H, Hata H and Ujiie H: Carotenoderma due to lycopenemia: A case report and evaluation of lycopene deposition in the skin. J Dermatol. 49:1320–1324. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Reich P, Shwachman H and Craig JM: Lycopenemia: A variant of carotenemia. N Engl J Med. 262:263–269. 1960. View Article : Google Scholar : PubMed/NCBI | |
|
Puah BP, Jalil J, Attiq A and Kamisah Y: New Insights into molecular mechanism behind anti-cancer activities of lycopene. Molecules. 26:38882021. View Article : Google Scholar : PubMed/NCBI | |
|
Tufail T, Bader Ul Ain H, Noreen S, Ikram A, Arshad MT and Abdullahi MA: Nutritional benefits of lycopene and beta-carotene: A comprehensive overview. Food Sci Nutr. 12:8715–8741. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Cakir MA and Helvacioglu I: Bioavailability and health effects of some carotenoids by different cooking methods. Int J Gastro Res. 2:70–77. 2023. | |
|
Shruti R, Arshi S and Rajat S: Effect of different processing and preservation techniques on lycopene: A mini review. Res J Pharm Tech. 16:2537–2542. 2023. | |
|
Wu X, Zhu C, Zhang M, Wang S, Yu J, Tian J and Hu Z: Effects of different processed tomatoes on carotenoid release and microbiota composition during in vitro gastrointestinal digestion and colonic fermentation. Food Funct. 14:10177–10187. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Geng T, Bao S, Sun X, Ma D, Zhang H, Ge Q, Liu X and Ma T: A clarification of concepts related to the digestion and absorption of carotenoids and a new standardized carotenoids bioavailability evaluation system. Food Chem. 400:1340602023. View Article : Google Scholar : PubMed/NCBI | |
|
Yao Y, Yang Z, Yin B, Goh HM, Toh DWK and Kim JE: Effects of dietary fat type and emulsification on carotenoid absorption: A randomized crossover trial. Am J Clin Nutr. 117:1017–1025. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Riedl J, Linseisen J, Hoffmann J and Wolfram G: Some dietary fibers reduce the absorption of carotenoids in women. J Nutr. 129:2170–2176. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Arballo J, Amengual J and Erdman JW Jr: Lycopene: A critical review of digestion, absorption, metabolism, and excretion. Antioxidants (Basel). 10:3422021. View Article : Google Scholar : PubMed/NCBI | |
|
Ozkan G, Gunal-Koroglu D, Karadag A, Capanoglu E, Cardoso SM, Al-Omari B, Calina D, Sharifi-Rad J and Cho WC: A mechanistic updated overview on lycopene as potential anticancer agent. Biomed Pharmacother. 161:1144282023. View Article : Google Scholar : PubMed/NCBI | |
|
Tang Y, Parmakhtiar B, Simoneau AR, Xie J, Fruehauf J, Lilly M and Zi X: Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels. Neoplasia. 13:108–119. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Yang G, Liu M, Quan Z, Wang L, Luo C, Wu X and Zheng Y: Lycopene enhances the sensitivity of castration-resistant prostate cancer to enzalutamide through the AKT/EZH2/androgen receptor signaling pathway. Biochem Biophys Res Commun. 613:53–60. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Chan YP, Chuang CH, Lee I and Yang NC: Lycopene in combination with sorafenib additively inhibits tumor metastasis in mice xenografted with lewis lung carcinoma cells. Front Nutr. 9:8869882022. View Article : Google Scholar : PubMed/NCBI | |
|
El-Masry TA, El-Nagar MMF, El Mahdy NA, Alherz FA, Taher R and Osman EY: Potential antitumor activity of combined lycopene and sorafenib against solid ehrlich carcinoma via targeting autophagy and apoptosis and suppressing proliferation. Pharmaceuticals (Basel). 17:5272024. View Article : Google Scholar : PubMed/NCBI | |
|
Alhoshani NM, Al-Zharani M, Almutairi B, Aljarba NH, Al-Johani NS, Alkeraishan N, AlKahtane AA, Alarifi S, Ali D and Alkahtani S: Antioxidant and anti-inflammatory activities of lycopene against 5-fluorouracil-induced cytotoxicity in Caco2 cells. Saudi Pharm J. 30:1665–1671. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Aktepe OH, Sahin TK, Guner G, Arik Z and Yalcin S: Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factor-kappa B (NF-ĸB) pathway. Turk J Med Sci. 51:368–374. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Holzapfel NP, Shokoohmand A, Wagner F, Landgraf M, Champ S, Holzapfel BM, Clements JA, Hutmacher DW and Loessner D: Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load. Am J Cancer Res. 7:1322–1336. 2017.PubMed/NCBI | |
|
Jiang X, Wu H, Zhao W, Ding X, You Q, Zhu F, Qian M and Yu P: Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells. Cancer Cell Int. 19:682019. View Article : Google Scholar : PubMed/NCBI | |
|
Peng M, Fan S, Li J, Zhou X, Liao Q, Tang F and Liu W: Programmed death-ligand 1 signaling and expression are reversible by lycopene via PI3K/AKT and Raf/MEK/ERK pathways in tongue squamous cell carcinoma. Genes Nutr. 17:32022. View Article : Google Scholar : PubMed/NCBI | |
|
Vaishampayan U, Hussain M, Banerjee M, Seren S, Sarkar FH, Fontana J, Forman JD, Cher ML, Powell I, Pontes JE and Kucuk O: Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr Cancer. 59:1–7. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Langner E, Lemieszek MK and Rzeski W: Lycopene, sulforaphane, quercetin, and curcumin applied together show improved antiproliferative potential in colon cancer cells in vitro. J Food Biochem. 43:e128022019. View Article : Google Scholar : PubMed/NCBI | |
|
Linnewiel-Hermoni K, Khanin M, Danilenko M, Zango G, Amosi Y, Levy J and Sharoni Y: The anti-cancer effects of carotenoids and other phytonutrients resides in their combined activity. Arch Biochem Biophys. 572:28–35. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Pan X, Niu X, Li Y, Yao Y and Han L: Preventive mechanism of lycopene on intestinal toxicity caused by cyclophosphamide chemotherapy in mice by regulating TLR4-MyD88/TRIF-TRAF6 signaling pathway and gut-liver axis. Nutrients. 14:44672022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu J, Hu Q and Shen S: Enhanced antitumor efficacy and attenuated cardiotoxicity of doxorubicin in combination with lycopene liposomes. J Liposome Res. 30:37–44. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sahin K, Tuzcu M, Sahin N, Ali S and Kucuk O: Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food Chem Toxicol. 48:2670–2674. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Turk G, Ceribasi AO, Sahna E and Atessahin A: Lycopene and ellagic acid prevent testicular apoptosis induced by cisplatin. Phytomedicine. 18:356–361. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tang C, Livingston MJ, Safirstein R and Dong Z: Cisplatin nephrotoxicity: New insights and therapeutic implications. Nat Rev Nephrol. 19:53–72. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Abdel-Latif R, Fathy M, Anwar HA, Naseem M, Dandekar T and Othman EM: Cisplatin-induced reproductive toxicity and oxidative stress: Ameliorative effect of kinetin. Antioxidants (Basel). 11:8632022. View Article : Google Scholar : PubMed/NCBI | |
|
Preet R, Mohapatra P, Das D, Satapathy SR, Choudhuri T, Wyatt MD and Kundu CN: Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC. Carcinogenesis. 34:277–286. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Moselhy SS and Al mslmani MA: Chemopreventive effect of lycopene alone or with melatonin against the genesis of oxidative stress and mammary tumors induced by 7,12 dimethyl(a)benzanthracene in sprague dawely female rats. Mol Cell Biochem. 319:175–180. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Limpens J, Schroder FH, de Ridder CM, Bolder CA, Wildhagen MF, Obermuller-Jevic UC, Kramer K and van Weerden WM: Combined lycopene and vitamin E treatment suppresses the growth of PC-346C human prostate cancer cells in nude mice. J Nutr. 136:1287–1293. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tang FY, Pai MH, Kuo YH and Wang XD: Concomitant consumption of lycopene and fish oil inhibits tumor growth and progression in a mouse xenograft model of colon cancer. Mol Nutr Food Res. 56:1520–1531. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Velmurugan B and Nagini S: Combination chemoprevention of experimental gastric carcinogenesis by s-allylcysteine and lycopene: Modulatory effects on glutathione redox cycle antioxidants. J Med Food. 8:494–501. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Malki AL, Moselhy SS and Refai MY: Synergistic effect of lycopene and tocopherol against oxidative stress and mammary tumorigenesis induced by 7,12-dimethyl[a]benzanthracene in female rats. Toxicol Ind Health. 28:542–548. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wu H, Wu Y, Cui Z and Hu L: Nutraceutical delivery systems to improve the bioaccessibility and bioavailability of lycopene: A review. Crit Rev Food Sci Nutr. 64:6361–6379. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Carvalho GC, Sabio RM and Chorilli M: An overview of properties and analytical methods for lycopene in organic nanocarriers. Crit Rev Anal Chem. 51:674–686. 2021.PubMed/NCBI | |
|
Ahmad R, Srivastava S, Ghosh S and Khare SK: Phytochemical delivery through nanocarriers: A review. Colloids Surf B Biointerfaces. 197:1113892021. View Article : Google Scholar : PubMed/NCBI | |
|
Llaguno-Munive M, Vazquez-Lopez MI and Garcia-Lopez P: Solid lipid nanoparticles, an alternative for the treatment of triple-negative breast cancer. Int J Mol Sci. 25:107122024. View Article : Google Scholar : PubMed/NCBI | |
|
Mirchandani Y, Patravale VB and S B: Solid lipid nanoparticles for hydrophilic drugs. J Control Release. 335:457–464. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ye J, Wang Q, Zhou X and Zhang N: Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm. 352:273–279. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Jain A, Sharma G, Kushwah V, Thakur K, Ghoshal G, Singh B, Jain S, Shivhare US and Katare OP: Fabrication and functional attributes of lipidic nanoconstructs of lycopene: An innovative endeavour for enhanced cytotoxicity in MCF-7 breast cancer cells. Colloids Surf B Biointerfaces. 152:482–491. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Santonocito D and Puglia C: Applications of lipid-based nanocarriers for parenteral drug delivery. Curr Med Chem. 29:4152–4169. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Katari O and Jain S: Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis. Expert Opin Drug Deliv. 18:1857–1872. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Singh A, Neupane YR, Panda BP and Kohli K: Lipid Based nanoformulation of lycopene improves oral delivery: formulation optimization, ex vivo assessment and its efficacy against breast cancer. J Microencapsul. 34:416–429. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Chen J, Shi L and Ma F: Polymeric nanoparticle-based nanovaccines for cancer immunotherapy. Mater Horiz. 10:361–392. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Pridgen EM, Alexis F and Farokhzad OC: Polymeric nanoparticle technologies for oral drug delivery. Clin Gastroenterol Hepatol. 12:1605–1610. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pridgen EM, Alexis F and Farokhzad OC: Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv. 12:1459–1473. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Miedema IHC, Zwezerijnen GJC, Huisman MC, Doeleman E, Mathijssen RHJ, Lammers T, Hu Q, van Dongen GAMS, Rijcken CJF, Vugts DJ, et al: PET-CT imaging of polymeric nanoparticle tumor accumulation in patients. Adv Mater. 34:e22010432022. View Article : Google Scholar : PubMed/NCBI | |
|
Bano S, Ahmed F, Khan F, Chaudhary SC and Samim M: Targeted delivery of thermoresponsive polymeric nanoparticle-encapsulated lycopene: In vitro anticancer activity and chemopreventive effect on murine skin inflammation and tumorigenesis. RSC Adv. 10:16637–16649. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Jain A, Kesharwani P, Garg NK, Jain A, Nirbhavane P, Dwivedi N, Banerjee S, Iyer AK and Iqbal Mohd Amin MC: Nano-constructed carriers loaded with antioxidant: Boon for cardiovascular system. Curr Pharm Des. 21:4456–4464. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yadollahi Z, Motiei M, Kazantseva N, Cisar J and Saha P: Whey protein isolate-chitosan polyelectrolyte nanoparticles as a drug delivery system. Molecules. 28:17242023. View Article : Google Scholar : PubMed/NCBI | |
|
Chatterton DEW, Smithers G, Roupas P and Brodkorb A: Bioactivity of β-lactoglobulin and α-lactalbumin-Technological implications for processing. Int Dairy J. 16:1229–1240. 2006. View Article : Google Scholar | |
|
Abbasi A, Emam-Djomeh Z, Mousavi MA and Davoodi D: Stability of vitamin D(3) encapsulated in nanoparticles of whey protein isolate. Food Chem. 143:379–383. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Jain A, Sharma G, Ghoshal G, Kesharwani P, Singh B, Shivhare US and Katare OP: Lycopene loaded whey protein isolate nanoparticles: An innovative endeavor for enhanced bioavailability of lycopene and anti-cancer activity. Int J Pharm. 546:97–105. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK and Chourasia MK: Nanoemulsion: Concepts, development and applications in drug delivery. J Control Release. 252:28–49. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li G, Zhang Z, Liu H and Hu L: Nanoemulsion-based delivery approaches for nutraceuticals: Fabrication, application, characterization, biological fate, potential toxicity and future trends. Food Funct. 12:1933–1953. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Huang RF, Wei YJ, Inbaraj BS and Chen BH: Inhibition of colon cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene. Int J Nanomedicine. 10:2823–2846. 2015.PubMed/NCBI | |
|
Moammeri A, Chegeni MM, Sahrayi H, Ghafelehbashi R, Memarzadeh F, Mansouri A, Akbarzadeh I, Abtahi MS, Hejabi F and Ren Q: Current advances in niosomes applications for drug delivery and cancer treatment. Mater Today Bio. 23:1008372023. View Article : Google Scholar : PubMed/NCBI | |
|
Mehrarya M, Gharehchelou B, Haghighi Poodeh S, Jamshidifar E, Karimifard S, Farasati Far B, Akbarzadeh I and Seifalian A: Niosomal formulation for antibacterial applications. J Drug Target. 30:476–493. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Kusdemir BC, Kozgus Guldu O, Yurt Kilcar A and Medine EI: Preparation and in vitro investigation of prostate-specific membrane antigen targeted lycopene loaded niosomes on prostate cancer cells. Int J Pharm. 640:1230132023. View Article : Google Scholar : PubMed/NCBI | |
|
Spiliotaki M, Mavroudis D, Kokotsaki M, Vetsika EK, Stoupis I, Matikas A, Kallergi G, Georgoulias V and Agelaki S: Expression of insulin-like growth factor-1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes. Mol Oncol. 12:21–32. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M and Figueiras A: Where is nano today and where is it headed? a review of nanomedicine and the dilemma of nanotoxicology. ACS Nano. 16:9994–10041. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ and Giovannucci E: Dietary lycopene, angiogenesis, and prostate cancer: A prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 106:djt4302014. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Y, Edwards A, Chen Z, Tseng TS, Li M, Gonzalez GV and Zhang K: Insufficient lycopene intake is associated with high risk of prostate cancer: A Cross-sectional study from the national health and nutrition examination survey (2003–2010). Front Public Health. 9:7925722021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Cui R, Xiao Y, Fang J and Xu Q: Effect of carotene and lycopene on the risk of prostate cancer: A systematic review and dose-response meta-analysis of observational studies. PLoS One. 10:e01374272015. View Article : Google Scholar : PubMed/NCBI | |
|
Ansari MS and Gupta NP: Lycopene: A novel drug therapy in hormone refractory metastatic prostate cancer. Urol Oncol. 22:415–420. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Gapstur SM, Giles GG, Giovannucci E, et al: Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: A pooled analysis of 18 prospective cohort studies. Am J Clin Nutr. 95:713–725. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Howard BV, Wylie-Rosett J, Anderson GL, Ho GY, et al: Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res. 68:329–337. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Walfisch S, Walfisch Y, Kirilov E, Linde N, Mnitentag H, Agbaria R, Sharoni Y and Levy J: Tomato lycopene extract supplementation decreases insulin-like growth factor-I levels in colon cancer patients. Eur J Cancer Prev. 16:298–303. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Kim JH, Lee J, Choi IJ, Kim YI, Kwon O, Kim H and Kim J: Dietary carotenoids intake and the risk of gastric cancer: A case-control study in Korea. Nutrients. 10:10312018. View Article : Google Scholar : PubMed/NCBI | |
|
Jung S, Wu K, Giovannucci E, Spiegelman D, Willett WC and Smith-Warner SA: Carotenoid intake and risk of colorectal adenomas in a cohort of male health professionals. Cancer Causes Control. 24:705–717. 2013.PubMed/NCBI | |
|
Ito Y, Kurata M, Hioki R, Suzuki K, Ochiai J and Aoki K: Cancer mortality and serum levels of carotenoids, retinol, and tocopherol: A population-based follow-up study of inhabitants of a rural area of Japan. Asian Pac J Cancer Prev. 6:10–15. 2005.PubMed/NCBI | |
|
Huang X, Gao Y, Zhi X, Ta N, Jiang H and Zheng J: Association between vitamin A, retinol and carotenoid intake and pancreatic cancer risk: Evidence from epidemiologic studies. Sci Rep. 6:389362016. View Article : Google Scholar : PubMed/NCBI | |
|
Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Theodore C, James ND, Turesson I, et al: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 351:1502–1512. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, Ambrosone CB and Thompson IM: Serum lycopene concentration and prostate cancer risk: Results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 20:638–646. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Jacobs EJ, Newton CC and McCullough ML: Lycopene, tomato products and prostate cancer-specific mortality among men diagnosed with nonmetastatic prostate cancer in the cancer prevention study II nutrition cohort. Int J Cancer. 138:2846–2855. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
van Breemen RB, Sharifi R, Viana M, Pajkovic N, Zhu D, Yuan L, Yang Y, Bowen PE and Stacewicz-Sapuntzakis M: Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: A randomized, controlled trial. Cancer Prev Res (Phila). 4:711–718. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Jatoi A, Burch P, Hillman D, Vanyo JM, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn PJ, Young C, et al: A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: Results of a phase II study from the North central cancer treatment group. Urology. 69:289–294. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Brown MJ, Ferruzzi MG, Nguyen ML, Cooper DA, Eldridge AL, Schwartz SJ and White WS: Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. Am J Clin Nutr. 80:396–403. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Unlu NZ, Bohn T, Clinton SK and Schwartz SJ: Carotenoid absorption from salad and salsa by humans is enhanced by the addition of avocado or avocado oil. J Nutr. 135:431–436. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Shareck M, Rousseau MC, Koushik A, Siemiatycki J and Parent ME: Inverse association between dietary intake of selected carotenoids and vitamin C and risk of lung cancer. Front Oncol. 7:232017. View Article : Google Scholar : PubMed/NCBI | |
|
Min KB and Min JY: Serum carotenoid levels and risk of lung cancer death in US adults. Cancer Sci. 105:736–743. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Prakash P, Russell RM and Krinsky NI: In vitro inhibition of proliferation of estrogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids. J Nutr. 131:1574–1580. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Aust O, Stahl W, Sies H, Tronnier H and Heinrich U: Supplementation with tomato-based products increases lycopene, phytofluene, and phytoene levels in human serum and protects against UV-light-induced erythema. Int J Vitam Nutr Res. 75:54–60. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zubair N, Kooperberg C, Liu J, Di C, Peters U and Neuhouser ML: Genetic variation predicts serum lycopene concentrations in a multiethnic population of postmenopausal women. J Nutr. 145:187–192. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Crowe-White KM, Voruganti VS, Talevi V, Dudenbostel T, Nagabooshanam VA, Locher JL and Ellis AC: Variation of serum lycopene in response to 100% watermelon juice: An exploratory analysis of genetic variants in a randomized controlled crossover study. Curr Dev Nutr. 4:nzaa1022020. View Article : Google Scholar : PubMed/NCBI | |
|
Moran NE, Thomas-Ahner JM, Fleming JL, McElroy JP, Mehl R, Grainger EM, Riedl KM, Toland AE, Schwartz SJ and Clinton SK: Single nucleotide polymorphisms in β-carotene oxygenase 1 are associated with plasma lycopene responses to a tomato-soy juice intervention in men with prostate cancer. J Nutr. 149:381–397. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Borel P, Desmarchelier C, Nowicki M and Bott R: Lycopene bioavailability is associated with a combination of genetic variants. Free Radic Biol Med. 83:238–244. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
D'Adamo CR, D'Urso A, Ryan KA, Yerges-Armstrong LM, Semba RD, Steinle NI, Mitchell BD, Shuldiner AR and McArdle PF: A common variant in the SETD7 gene predicts serum lycopene concentrations. Nutrients. 8:822016. View Article : Google Scholar : PubMed/NCBI | |
|
Cui Y, Shikany JM, Liu S, Shagufta Y and Rohan TE: Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study. Am J Clin Nutr. 87:1009–1018. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, Dai Q, Dorgan JF, Franke AA, Gao YT, Goodman MT, et al: Circulating carotenoids and risk of breast cancer: Pooled analysis of eight prospective studies. J Natl Cancer Inst. 104:1905–1916. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yan B, Lu MS, Wang L, Mo XF, Luo WP, Du YF and Zhang CX: Specific serum carotenoids are inversely associated with breast cancer risk among Chinese women: A case-control study. Br J Nutr. 115:129–137. 2016. View Article : Google Scholar : PubMed/NCBI |
